Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Silo Pharma ( (SILO) ) just unveiled an announcement.
On June 27, 2025, Silo Pharma disclosed that it had fallen out of compliance with Nasdaq’s minimum bid price rule, which requires listed stocks to maintain a bid price of at least $1.00 per share for 30 consecutive business days, and the company did not regain compliance by the initial deadline of December 24, 2025. On December 24, 2025, Nasdaq granted Silo Pharma a second 180‑day compliance period, extending the deadline to June 22, 2026, based on the company’s satisfaction of other listing criteria and its stated intention to cure the deficiency, including the potential use of a reverse stock split if needed; during this extension the stock will continue trading under the SILO symbol, but failure to lift the bid price above $1.00 for at least 10 consecutive business days by the new deadline could result in delisting and a possible appeal process, underscoring ongoing listing risk for shareholders.
More about Silo Pharma
Silo Pharma, Inc. is a publicly traded company listed on the Nasdaq Capital Market under the ticker symbol SILO. The company’s shares are subject to Nasdaq’s continued listing standards, including minimum bid price and market value requirements that apply to smaller-cap issuers on the exchange.
Average Trading Volume: 408,498
Technical Sentiment Signal: Strong Sell
Current Market Cap: $4.85M
See more insights into SILO stock on TipRanks’ Stock Analysis page.